Related Experiment Videos
T cell epitopes in human papilloma virus proteins
1Imperial Cancer Research Fund, University College London Medical School, Courtauld Institute, UK.
Behring Institute Mitteilungen
|July 1, 1994
Summary
Human papillomavirus (HPV) infection is linked to various diseases. Research explores T cell responses to transforming HPV types, like HPV16, to develop effective vaccines.
Area of Science:
- Immunology
- Virology
- Oncology
Background:
- Human papillomavirus (HPV) infection causes diseases including warts, condylomata, and cervical carcinoma.
- While immune control is evident for wart-causing HPV types, T cell responses to oncogenic HPV types remain unclear.
- HPV16 is a transforming virus frequently found in cervical cancer and cervical intraepithelial neoplasia (CIN).
Purpose of the Study:
- To investigate the T cell response in patients infected with transforming HPV types.
- To identify T cell epitopes within HPV16 proteins.
- To inform the development of immune-stimulating anti-HPV16 vaccines.
Main Methods:
- Analysis of T cell responses (Th and CTL) to HPV16 proteins.
- Identification of specific T cell epitopes.
Main Results:
- Several T helper (Th) and cytotoxic T lymphocyte (CTL) epitopes have been identified in HPV16 proteins.
- Despite apparent low immunogenicity, specific epitopes are recognizable by T cells.
Conclusions:
- Knowledge of T cell recognizable proteins from transforming HPV types, particularly HPV16, is crucial.
- This understanding may facilitate the design of novel anti-HPV16 vaccines to stimulate immune responses against cervical cancer.